Antisense oligonucleotide-based switches for conditional translation of synthetic mRNA. [PDF]
Combes F, Pettersson FJ, Bui TH.
europepmc +1 more source
Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS. [PDF]
McEachin ZT +32 more
europepmc +1 more source
A sweet barrier to gene silencing: Glucose metabolism interferes with antisense oligonucleotide therapy. [PDF]
Duan S, Zhang W, Cao H.
europepmc +1 more source
Gapmer Antisense Oligonucleotide Targeting E-Cadherin Rescues Abnormal Keratinization in X-Linked Ichthyosis Models. [PDF]
Kwak JH +6 more
europepmc +1 more source
Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids. [PDF]
Faravelli I +22 more
europepmc +1 more source
CD47 antisense oligonucleotide treatment improves glucose homeostasis and alleviates dyslipidemia in aged male mice. [PDF]
Gwag T +7 more
europepmc +1 more source
A therapeutic antisense oligonucleotide encompassing 2'-<i>O</i>-methoxyethyl modification triggers unique perturbation of the transcriptome. [PDF]
Ottesen EW +5 more
europepmc +1 more source
Atrophin-1 antisense oligonucleotide provides robust protection from pathology in a fully humanized DRPLA model. [PDF]
Smith VL +17 more
europepmc +1 more source
From Genomic Diagnosis to Personalized RNA Medicine: Advances in Next-Generation Sequencing and N-of-1 Antisense Oligonucleotide Therapies for Rare Genetic Diseases. [PDF]
Rodriguez Carstens P +2 more
europepmc +1 more source

